[1]Palmer;VanZijl;Denny;Wilson[JournalofMedicinalChemistry,1995,vol.38,#7,p.1229-1241]
[2]Chen,Shiuan;Knox,Richard;Lewis,AlexanderD.;Friedlos,Frank;Workman,Paul;Deng,PaulisS.K.;Fung,Maisie;Ebenstein,Donna;Wu,Kebin;Tsai,Ta-Ming[MolecularPharmacology,1995,vol.47,#5,p.934-939]
[3]AbuKhader,Majed;Heap,John;DeMatteis,Cristina;Kellam,Barrie;Doughty,StephenW.;Minton,Nigel;Paoli,Massimo[JournalofMedicinalChemistry,2005,vol.48,#24,p.7714-7719]
[1]AbuKhader,Majed;Heap,John;DeMatteis,Cristina;Kellam,Barrie;Doughty,StephenW.;Minton,Nigel;Paoli,Massimo[JournalofMedicinalChemistry,2005,vol.48,#24,p.7714-7719]
[1]Jackson,JenniferC.;Duffy,SeanP.;Hess,KennethR.;Mehl,RyanA.[JournaloftheAmericanChemicalSociety,2006,vol.128,#34,p.11124-11127]
[1]CurrentPatentAssignee:GORDIANPHARMA-WO2007/74344,2007,A1Locationinpatent:Page/Pagecolumn63-65
61837-26-1
[1]Çelik,Ayhan;Yetiş,Gülden[BioorganicandMedicinalChemistry,2012,vol.20,#11,p.3540-3550]
[2]Ball,Patrick;Thompson,Emma;Anderson,Simon;Gwenin,Vanessa;Gwenin,Chris[EuropeanJournalofPharmaceuticalSciences,2019,vol.127,p.217-224]
Title: Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
Journal: Chemical research in toxicology 20180219
Title: Creation and screening of a multi-family bacterial oxidoreductase library to discover novel nitroreductases that efficiently activate the bioreductive prodrugs CB1954 and PR-104A.
Journal: Biochemical pharmacology 20130415
Title: An unusually cold active nitroreductase for prodrug activations.
Journal: Bioorganic & medicinal chemistry 20120601
Title: Noninvasive optical imaging of nitroreductase gene-directed enzyme prodrug therapy system in living animals.
Journal: Gene therapy 20120301
Title: In silico screening reveals structurally diverse, nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-κB signaling.
Journal: Molecular cancer therapeutics 20120101
Title: The synthesis of 2-nitroaryl-1,2,3,4-tetrahydroisoquinolines, nitro-substituted 5,6-dihydrobenzimidazo[2,1-a]isoquinoline N-oxides and related heterocycles as potential bioreducible substrates for the enzymes NAD(P)H: quinone oxidoreductase 1 and E. coli nitroreductase.
Journal: Bioorganic & medicinal chemistry letters 20111215
Title: Colloidal gold modified with a genetically engineered nitroreductase: toward a novel enzyme delivery system for cancer prodrug therapy.
Journal: Langmuir : the ACS journal of surfaces and colloids 20111206
Title: Insights into the redox cycle of human quinone reductase 2.
Journal: Free radical research 20111001
Title: Co-expression of herpes simplex virus thymidine kinase and Escherichia coli nitroreductase by an hTERT-driven adenovirus vector in breast cancer cells results in additive anti-tumor effects.
Journal: Oncology reports 20110701
Title: NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels.
Journal: PloS one 20110101
Title: Activation of nitrofurazone by azoreductases: multiple activities in one enzyme.
Journal: Scientific reports 20110101
Title: uvrB gene deletion enhances SOS chromotest sensitivity for nitroreductases that preferentially generate the 4-hydroxylamine metabolite of the anti-cancer prodrug CB1954.
Journal: Journal of biotechnology 20101001
Title: Quinone oxidoreductase-2-mediated prodrug cancer therapy.
Journal: Science translational medicine 20100714
Title: Transgenic mice expressing nitroreductase gene under the control of the podocin promoter: a new murine model of inductible glomerular injury.
Journal: Virchows Archiv : an international journal of pathology 20100301
Title: Bystander or no bystander for gene directed enzyme prodrug therapy.
Journal: Molecules (Basel, Switzerland) 20091110
Title: Antivector and tumor immune responses following adenovirus-directed enzyme prodrug therapy for the treatment of prostate cancer.
Journal: Human gene therapy 20091101
Title: Steady-state and stopped-flow kinetic studies of three Escherichia coli NfsB mutants with enhanced activity for the prodrug CB1954.
Journal: Biochemistry 20090818
Title: A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].
Journal: Molecular therapy : the journal of the American Society of Gene Therapy 20090701
Title: E. coli NfsA: an alternative nitroreductase for prodrug activation gene therapy in combination with CB1954.
Journal: British journal of cancer 20090616
Title: Antitumor activity of a selectively replication competent herpes simplex virus (HSV) with enzyme prodrug therapy.
Journal: Anticancer research 20090601
Title: Mechanism of CB1954 reduction by Escherichia coli nitroreductase.
Journal: Biochemical Society transactions 20090401
Title: A new in vitro model for stem cell differentiation and interaction.
Journal: Stem cell research 20090301
Title: A mammalianized synthetic nitroreductase gene for high-level expression.
Journal: BMC cancer 20090101
Title: Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Journal: Journal of medicinal chemistry 20081113
Title: The NprA nitroreductase required for 2,4-dinitrophenol reduction in Rhodobacter capsulatus is a dihydropteridine reductase.
Journal: Environmental microbiology 20081101
Title: E. coli nitroreductase/CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2.
Journal: Cancer gene therapy 20081101
Title: Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104.
Journal: Cancer research 20081001
Title: Gene therapy for the treatment of hip prosthesis loosening: adverse events in a phase 1 clinical study.
Journal: Human gene therapy 20081001
Title: Metabolic activation of the antitumor drug 5-(Aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by NO synthases.
Journal: Chemical research in toxicology 20080401
Title: Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo.
Journal: Gene therapy 20080301
Title: SALMON: solvent accessibility, ligand binding, and mapping of ligand orientation by NMR spectroscopy.
Journal: Journal of medicinal chemistry 20080110
Title: Combining gene and immunotherapy for prostate cancer.
Journal: Prostate cancer and prostatic diseases 20080101
Title: The nitroreductase prodrug SN 28343 enhances the potency of systemically administered armed oncolytic adenovirus ONYX-411(NTR).
Journal: Cancer gene therapy 20071201
Title: Hepatic nitroreduction, toxicity and toxicokinetics of the anti-tumour prodrug CB 1954 in mouse and rat.
Journal: Toxicology 20071030
Title: Synthesis of cryptolepine analogues as potential bioreducible anticancer agents.
Journal: Bioorganic & medicinal chemistry 20071001
Title: Validation of nitroreductase, a prodrug-activating enzyme, mediated cell death in embryonic zebrafish (Danio rerio).
Journal: Comparative medicine 20070601
Title: Ablation of central nervous system progenitor cells in transgenic rats using bacterial nitroreductase system.
Journal: Journal of neuroscience research 20070501
Title: Kinetic and structural characterisation of Escherichia coli nitroreductase mutants showing improved efficacy for the prodrug substrate CB1954.
Journal: Journal of molecular biology 20070427
Title: Direct positive selection for improved nitroreductase variants using SOS triggering of bacteriophage lambda lytic cycle.
Journal: Gene therapy 20070401
Title: Synthesis and structure-activity relationships for 2,4-dinitrobenzamide-5-mustards as prodrugs for the Escherichia coli nfsB nitroreductase in gene therapy.
Journal: Journal of medicinal chemistry 20070322
Title: NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20070301
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20070301
Title: Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo.
Journal: British journal of cancer 20061106
Title: Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor.
Journal: British journal of cancer 20061106
Title: Application of a microfluidic reactor for screening cancer prodrug activation using silica-immobilized nitrobenzene nitroreductase.
Journal: Biomacromolecules 20060901
Title: NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
Journal: Biochemical pharmacology 20060728
Title: Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.
Journal: Journal of medicinal chemistry 20060713
Title: Hypoxia: targeting the tumour.
Journal: Anti-cancer agents in medicinal chemistry 20060701
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Nitroreductase-based therapy of prostate cancer, enhanced by raising expression of heat shock protein 70, acts through increased anti-tumour immunity.
Journal: Cancer immunology, immunotherapy : CII 20060301
Title: Delivery of the bacterial nitroreductase gene into endothelial cells prolongs the survival of tumour-bearing mice by bystander mechanisms.
Journal: International journal of oncology 20060201
Title: New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution.
Journal: Molecular cancer therapeutics 20060101
Title: Aerobic 2- and 4-nitroreduction of CB 1954 by human liver.
Journal: Toxicology 20051215
Title: Binding of the anticancer prodrug CB1954 to the activating enzyme NQO2 revealed by the crystal structure of their complex.
Journal: Journal of medicinal chemistry 20051201
Title: Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954.
Journal: Human gene therapy 20051201
Title: Towards gene therapy in prosthesis loosening: efficient killing of interface cells by gene-directed enzyme prodrug therapy with nitroreductase and the prodrug CB1954.
Journal: The journal of gene medicine 20051101
Title: Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954.
Journal: Biochemical and biophysical research communications 20051014
Title: Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.
Journal: Gene therapy 20050801
Title: Antitumor immune responses mediated by adenoviral GDEPT using nitroreductase/CB1954 is enhanced by high-level coexpression of heat shock protein 70.
Journal: Cancer gene therapy 20050601
Title: Nitroreductase: a prodrug-activating enzyme for cancer gene therapy.
Journal: Clinical and experimental pharmacology & physiology 20041101
Title: Enhanced efficacy of Escherichia coli nitroreductase/CB1954 prodrug activation gene therapy using an E1B-55K-deleted oncolytic adenovirus vector.
Journal: Gene therapy 20040701
Title: Aziridinyldinitrobenzamides: synthesis and structure-activity relationships for activation by E. coli nitroreductase.
Journal: Journal of medicinal chemistry 20040603
Title: Genes in the service of therapeutic index: progress for virus-directed enzyme prodrug therapy.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040501
Title: 2-Amino metabolites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT.
Journal: British journal of cancer 20040308
Title: Enzyme-catalyzed activation of anticancer prodrugs.
Journal: Pharmacological reviews 20040301
Title: Methods to improve efficacy in suicide gene therapy approaches: targeting prodrug-activating enzymes carboxypeptidase G2 and nitroreductase to different subcellular compartments.
Journal: Methods in molecular medicine 20040101
Title: The nitroreductase/CB1954 enzyme-prodrug system.
Journal: Methods in molecular medicine 20040101
Title: Quinone reductase-mediated nitro-reduction: clinical applications.
Journal: Methods in enzymology 20040101
Title: The gene suicide system Ntr/CB1954 causes ablation of differentiated 3T3L1 adipocytes by apoptosis.
Journal: Biological research 20040101
Title: Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
Journal: Journal of medicinal chemistry 20031204
Title: Clostridia in cancer therapy.
Journal: Nature reviews. Microbiology 20031201
Title: Bystander cell killing spreading from endothelial to tumor cells in a three-dimensional multicellular nodule model after Escherichia coli nitroreductase gene delivery.
Journal: Biochemical and biophysical research communications 20031128
Title: Nitroaryl phosphoramides as novel prodrugs for E. coli nitroreductase activation in enzyme prodrug therapy.
Journal: Journal of medicinal chemistry 20031106
Title: Studies on the nitroreductase prodrug-activating system. Crystal structures of complexes with the inhibitor dicoumarol and dinitrobenzamide prodrugs and of the enzyme active form.
Journal: Journal of medicinal chemistry 20030911
Title: Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracil.
Journal: British journal of cancer 20030901
Title: Generation of Escherichia coli nitroreductase mutants conferring improved cell sensitization to the prodrug CB1954.
Journal: Cancer research 20030901
Title: Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.
Journal: British journal of cancer 20030804
Title: Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase.
Journal: Journal of medicinal chemistry 20030605
Title: Effect of nitroreduction on the alkylating reactivity and cytotoxicity of the 2,4-dinitrobenzamide-5-aziridine CB 1954 and the corresponding nitrogen mustard SN 23862: distinct mechanisms of bioreductive activation.
Journal: Chemical research in toxicology 20030401
Title: Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vector.
Journal: International journal of cancer 20030310
Title: Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.
Journal: Oncogene 20030123
Title: CB 1954: from the Walker tumor to NQO2 and VDEPT.
Journal: Current pharmaceutical design 20030101
Title: Selective ablation of olfactory receptor neurons without functional impairment of vomeronasal receptor neurons in OMP-ntr transgenic mice.
Journal: The European journal of neuroscience 20021201
Title: [The trends in new drugs for the prostate cancer].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20021201
Title: Inducible ablation of adipocytes in adult transgenic mice expressing the E. coli nitroreductase gene.
Journal: The Journal of endocrinology 20021101
Title: Gene therapy trials: a patient pathway.
Journal: Nursing standard (Royal College of Nursing (Great Britain) : 1987) 20021001
Title: Current progress in suicide gene therapy for cancer.
Journal: World journal of surgery 20020701
Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
Journal: The Journal of biological chemistry 20020419
Title: Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures.
Journal: Cancer research 20020301
Title: Bacillus amyloliquefaciens orthologue of Bacillus subtilis ywrO encodes a nitroreductase enzyme which activates the prodrug CB 1954.
Journal: Microbiology (Reading, England) 20020101
Title: Inhibition of myc-dependent breast tumor formation in transgenic mice.
Journal: Breast cancer research and treatment 20020101
Title: Hypoxia-inducible regulation of a prodrug-activating enzyme for tumor-specific gene therapy.
Journal: Neoplasia (New York, N.Y.) 20020101
Title: Nitroreductase-based GDEPT.
Journal: Current pharmaceutical design 20020101
Title: British Cancer Research Meeting, 30 June-3 July 2002, Glasgow.
Journal: Breast cancer research : BCR 20020101
Title: Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
Journal: Oncogene 20011122
Title: High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy 20011001
Title: Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20010901
Title: Appropriate subcellular localisation of prodrug-activating enzymes has important consequences for suicide gene therapy.
Journal: International journal of cancer 20010701
Title: Conditional ablation of neurones in transgenic mice.
Journal: Journal of neurobiology 20010605
Title: Inducible ablation of astrocytes shows that these cells are required for neuronal survival in the adult brain.
Journal: Glia 20010601
Title: E. coli nitroreductase/CB1954: in vitro studies into a potential system for feline cancer gene therapy.
Journal: Veterinary journal (London, England : 1997) 20010501
Title: Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: a well-tolerated therapy for established solid tumors.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy 20010201
Title: Demonstration of the activation of prodrug CB 1954 using human DT-diaphorase mutant Q104Y-transfected MDA-MB-231 cells and mouse xenograft model.
Journal: Archives of biochemistry and biophysics 20010101
Title: Gene therapy for colorectal cancer: therapeutic potential.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20010101
Title: Knox RJ,et al. Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy. Cancer Res. 2000 Aug 1;60(15):4179-86.
Title: Knox RJ, et al. CB 1954: from the Walker tumor to NQO2 and VDEPT. Curr Pharm Des. 2003;9(26):2091-104.
Title: Green NK, et al. Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronicadenovirus vector. Int J Cancer. 2003 Mar 10;104(1):104-12.
Title: Drabek D, et al. The expression of bacterial nitroreductase in transgenic mice results in specific cell killing by the prodrug CB1954. Gene Ther. 1997 Feb;4(2):93-100.
